Tysabri every eight weeks may cut PML risk
Tysabri every eight weeks may cut PML risk
Preliminary findings from an ongoing study of multiple sclerosis patients suggest the dosing interval for Tysabri can be as much as doubled from the label-recommended standard without sacrificing efficacy, and with potentially less risk of progressive multifocal leukoencephalopathy (PML) -- even among patients with more than average PML risk, researchers claim... Read More - http://www.ms-uk.org/MSnews
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 2312 Views
-
Last post by NHE
-
- 6 Replies
- 6712 Views
-
Last post by ElliotB
-
- 0 Replies
- 1364 Views
-
Last post by NHE
-
- 0 Replies
- 3434 Views
-
Last post by NHE
-
- 1 Replies
- 1027 Views
-
Last post by NHE
-
- 1 Replies
- 1523 Views
-
Last post by NHE
-
- 11 Replies
- 3388 Views
-
Last post by NHE
-
- 0 Replies
- 3163 Views
-
Last post by NHE
-
- 0 Replies
- 1437 Views
-
Last post by NHE